Twitxy Saved

Jim Breyer

Verified account This account is verified. Learn more

@jimihendrixlive

breyercapital.com, Austin TX, venture capital/investing/venture philanthropy,conservation,Smiles and Laughter
Austin breyercapital.com Joined May 2007
27K Following 25K Followers 1.5K Posts

Latest posts 5

Pinned post

Jim Breyer Verified account @jimihendrixlive
I'm grateful and humbled to be featured on one of the covers of this year’s Forbes 400 issue.

In my interview, I shared that Breyer Capital is especially energized by the intersection of AI and the life sciences. Healthcare is at an inflection point: scientific discovery is accelerating, yet the systems of care have not kept pace. The gap between what’s possible and what’s practiced is widening, and that dislocation represents one of the defining opportunities of our time.

One example of this transformation is OpenEvidence, which this week announced a $200 million financing at a $6 billion valuation led by Google Ventures. Open Evidence now supports over 15 million clinical consultations each month, empowering physicians with trusted, evidence-based insights from leading medical journals.

At Breyer Capital, we invest where science, computation, and care converge. Breakthroughs in AI, precision medicine, and data infrastructure are reshaping how healthcare is delivered, measured, and paid for. Our goal isn’t to optimize broken systems, but to help build new ones: rearchitecting the clinical stack, compressing biomedical time, and creating evidence frameworks that learn in real time.

Thank you to Forbes for the recognition, and to the extraordinary scientists, clinicians, and entrepreneurs who continue to show us what the future of health can look like.
39 replies 16 reposts 341 likes 242K views View on X
Jim Breyer Verified account @jimihendrixlive
Fantastic news @fidjissimo
Fidji Simo Verified account @fidjissimo 4d
And just like that, we have our first clinical trial and pharma partnership in the works! We’re teaming up with Prolong to take the drug they developed for stroke and see if it can help our patients with ME/CFS by increasing oxygen delivery and blood flow. Thanks to the 200TB of data @chroniclebioAI has amassed, combined with our AI engine, we are identifying patients that show hypoxia so we can focus this trial on them.
This is really the promise of the company: understanding biology at such a deep level that we can match the exact right patients to the exact right drugs and massively increase the likelihood of success of trials.
Going from company creation to first trial in less than two years is pretty cool, but there’s still a lot of work to be done to prove we can improve patients’ lives. One step at a time.
View quoted post on X
1 replies 0 reposts 15 likes 1.9K views View on X
Jim Breyer Verified account @jimihendrixlive
For years, I’ve recommended @nvidia to founders, partners, and fellow investors. The technical moat, product velocity, and market execution that @JensenHuang and his team have built over three decades set a new standard for modern technology leadership.

My conviction dates back many years. At Davos in January 2019, when @nvidia was trading around $3.50 per share, split-adjusted, I told @CNBC that I loved NVIDIA for the long term. I also predicted that AI-first companies would eventually dominate the ranks of the world’s largest companies.

In 2021, I emphasized the significant technological lead held by NVIDIA and America's leading semiconductor companies. In 2022, I said, “NVIDIA is so far ahead of everyone else… I love NVIDIA.” In 2023, I described NVIDIA as looking “unstoppable over the next three years.” And in 2024, I reiterated: “I’ve been pounding the table on NVIDIA… I still am.”

Over the past six years, I've had the privilege of learning an enormous amount from Jensen and his extraordinary team at NVIDIA. I've also learned so much from @LisaSu, a good friend, and her remarkable team at @AMD. Both companies are testaments to the extraordinary innovation and technological leadership of the American semiconductor industry.

Through every stage of the AI revolution, my conviction in NVIDIA and its leadership has remained unwavering.

And yet, even with that conviction, I never could have anticipated a moment like this.

It is a powerful reminder that investing, regardless of financial performance, remains a deeply person-centered business. Behind every extraordinary company are extraordinary people, relationships, and decades of hard work.

It is always humbling.

@SaraEisen, @andrewrsorkin, @BeckyQuick
16 replies 7 reposts 107 likes 11K views View on X
Jim Breyer Verified account @jimihendrixlive
Fidji Simo Verified account @fidjissimo 6d
Nothing like waking up to dozens of congrats for taking a job you did not take! While I loved my time at Meta, no, I am not going back! I’m still dealing with severe health issues and focusing all my energy on finding cures for myself and millions of patients like me. And while it’s been a hard time personally, it has also been the most meaningful mission I have ever worked on.
View quoted post on X